Equities

ASKA Pharmaceutical Holdings Co Ltd

ASKA Pharmaceutical Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)2,207.00
  • Today's Change16.00 / 0.73%
  • Shares traded88.30k
  • 1 Year change+35.98%
  • Beta1.2662
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue62,84360,46156,607
OPERATING EXPENSES
Cost of revenue total32,17831,87630,255
Selling, general and admin. expenses, total19,43619,24917,958
Depreciation/amortization------
Unusual expense(income)----8,142
Other operating expenses, total1.001.001.00
Total operating expense56,34355,35359,954
Operating income6,5005,108(3347)
Other, net(167)(68)(74)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes9,8625,3576,163
Provision for income taxes2,3161,1181,873
Net income after taxes7,5464,2394,290
Minority interest------
Net income before extra. Items7,5464,2394,290
Total extraordinary items------
Net income7,5464,2394,290
Inc.avail. to common excl. extra. Items7,5454,2384,290
Inc.avail. to common incl. extra. Items7,5454,2384,290
EPS RECONCILIATION
Basic/primary weighted average shares282828
Basic/primary eps excl. extra items266150151
Basic/primary eps incl. extra items266150151
Dilution adjustment------
Diluted weighted average shares282828
Diluted eps excl. extra items266150151
Diluted eps incl. extra items266150151
COMMON STOCK DIVIDENDS
DPS - common stock primary issue401615
Gross dividend - common stock1,132452424
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental405056
SUPPLEMENTAL INCOME
Depreciation, supplemental2,6623,1272,885
Total special items1352(1240)
NORMALISED INCOME
Normalized income before taxes9,8755,4094,923
Effect of special items on income taxes3.0511(377)
Income tax excluding impact of special items2,3191,1291,496
Normalized income after tax7,5564,2803,427
Normalized income avail. to common7,5554,2793,427
Basic normalized EPS267152121
Diluted normalized EPS267152121
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.